Literature DB >> 25451870

Bioinformatics for clinical next generation sequencing.

Gavin R Oliver1, Steven N Hart1, Eric W Klee2.   

Abstract

BACKGROUND: Next generation sequencing (NGS)-based assays continue to redefine the field of genetic testing. Owing to the complexity of the data, bioinformatics has become a necessary component in any laboratory implementing a clinical NGS test. CONTENT: The computational components of an NGS-based work flow can be conceptualized as primary, secondary, and tertiary analytics. Each of these components addresses a necessary step in the transformation of raw data into clinically actionable knowledge. Understanding the basic concepts of these analysis steps is important in assessing and addressing the informatics needs of a molecular diagnostics laboratory. Equally critical is a familiarity with the regulatory requirements addressing the bioinformatics analyses. These and other topics are covered in this review article.
SUMMARY: Bioinformatics has become an important component in clinical laboratories generating, analyzing, maintaining, and interpreting data from molecular genetics testing. Given the rapid adoption of NGS-based clinical testing, service providers must develop informatics work flows that adhere to the rigor of clinical laboratory standards, yet are flexible to changes as the chemistry and software for analyzing sequencing data mature.
© 2014 American Association for Clinical Chemistry.

Mesh:

Year:  2014        PMID: 25451870     DOI: 10.1373/clinchem.2014.224360

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  36 in total

Review 1.  The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).

Authors:  Larry Tremaine; William Brian; Terrye DelMonte; Stephan Francke; Peter Groenen; Keith Johnson; Lei Li; Kimberly Pearson; Jean-Claude Marshall
Journal:  Pharmacogenomics       Date:  2015-11-30       Impact factor: 2.533

2.  Comparison of library construction kits for mRNA sequencing in the Illumina platform.

Authors:  Yong-Soo Park; Songmi Kim; Dong-Guk Park; Dong Hee Kim; Kyeong-Wook Yoon; Wonseok Shin; Kyudong Han
Journal:  Genes Genomics       Date:  2019-07-26       Impact factor: 1.839

3.  Herpes Simplex Virus Disease Management and Diagnostics in the Era of High-Throughput Sequencing.

Authors:  Utsav Pandey; Moriah L Szpara
Journal:  Clin Microbiol Newsl       Date:  2019-02-19

Review 4.  Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results.

Authors:  Shunchao Bao; Xinyu Wang; Mo Li; Zhao Gao; Dongdong Zheng; Dihan Shen; Linlin Liu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 5.  Implementing genome-driven personalized cardiology in clinical practice.

Authors:  Ares Pasipoularides
Journal:  J Mol Cell Cardiol       Date:  2018-01-16       Impact factor: 5.000

6.  Dynamic software design for clinical exome and genome analyses: insights from bioinformaticians, clinical geneticists, and genetic counselors.

Authors:  Casper Shyr; Andre Kushniruk; Clara D M van Karnebeek; Wyeth W Wasserman
Journal:  J Am Med Inform Assoc       Date:  2015-06-27       Impact factor: 4.497

7.  Establishing the precise evolutionary history of a gene improves prediction of disease-causing missense mutations.

Authors:  Ogun Adebali; Alexander O Reznik; Daniel S Ory; Igor B Zhulin
Journal:  Genet Med       Date:  2016-02-18       Impact factor: 8.822

8.  LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137.

Authors:  Yalin Lu; Gaochao Guo; Rujun Hong; Xingjie Chen; Yan Sun; Fang Liu; Zhimeng Zhang; Xun Jin; Jun Dong; Kai Yu; Xuejun Yang; Yang Nan; Qiang Huang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

9.  Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9.

Authors:  Weihang Li; Ziyi Ding; Dong Wang; Chengfei Li; Yikai Pan; Yingjing Zhao; Hongzhe Zhao; Tianxing Lu; Rui Xu; Shilei Zhang; Bin Yuan; Yunlong Zhao; Yanjiang Yin; Yuan Gao; Jing Li; Ming Yan
Journal:  Cancer Cell Int       Date:  2021-07-14       Impact factor: 5.722

Review 10.  Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives.

Authors:  Vincenza Precone; Valentina Del Monaco; Maria Valeria Esposito; Fatima Domenica Elisa De Palma; Anna Ruocco; Francesco Salvatore; Valeria D'Argenio
Journal:  Biomed Res Int       Date:  2015-11-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.